Pharmaceutical composition containing sucralfate
    6.
    发明授权
    Pharmaceutical composition containing sucralfate 失效
    含有硫糖铝的药物组合物

    公开(公告)号:US5985843A

    公开(公告)日:1999-11-16

    申请号:US930263

    申请日:1997-09-26

    Abstract: Disclosed is a pharmaceutical preparation that contains sucralfate is the presence of another drug and which consists of a delayed release fraction of sucralfate and an immediate release fraction of the another drug. The preparation exhibits an outstanding feature such that when administered, the drug coexistent with the sucralfate can maintain its inherent absorption characteristics without being adsorbed, trapped or otherwise affected by the sucralfate.

    Abstract translation: PCT No.PCT / JP96 / 00891 Sec。 371日期:1997年9月26日 102(e)1997年9月26日PCT PCT 1996年4月2日PCT公布。 WO96 / 31218 PCT出版物 日期1996年10月10日公开是含有硫糖铝的药物制剂,是另一种药物的存在,其由硫糖铝的延迟释放部分和另一种药物的立即释放部分组成。 该制剂表现出突出的特征,使得当施用时,与硫糖铝共存的药物可以保持其固有的吸收特征,而不被硫糖铝吸附,捕获或以其它方式影响。

    Stabilized active forms of vitamin D.sub.3
    7.
    发明授权
    Stabilized active forms of vitamin D.sub.3 失效
    稳定的活性形式的维生素D3

    公开(公告)号:US4836957A

    公开(公告)日:1989-06-06

    申请号:US828596

    申请日:1986-02-11

    CPC classification number: A61K31/59 A61K47/183 A61K9/0014 A61K9/0019

    Abstract: A preparation containing an active form of vitamin D.sub.3 which is stabilized by incorporation of an amino acid that is neither one containing a sulfur atom or an acid amino group in its structure, nor an acidic amino acid, nor a salt of a basic amino acid is disclosed. Examples of said amino acids that may be used as stabilizers of the active form of vitamin D.sub.3 include neutral amino acids such as alanine, valine, proline, phenylalanine, tryptophan, leucine, isoleucine, glycine and serine, and basic amino acids such as lysine, arginine and histidine.

    Abstract translation: 含有活性形式的维生素D3的制剂,其结构中并不含有硫原子或酸性氨基的氨基酸,也不含酸性氨基酸,也不含碱性氨基酸的盐, 披露 可用作活性形式的维生素D3的稳定剂的所述氨基酸的实例包括中性氨基酸,例如丙氨酸,缬氨酸,脯氨酸,苯丙氨酸,色氨酸,亮氨酸,异亮氨酸,甘氨酸和丝氨酸,以及碱性氨基酸如赖氨酸, 精氨酸和组氨酸。

Patent Agency Ranking